Wednesday, 3 July 2019

FDA approves Karyopharm Therapeutics' blood cancer drug

The U.S. Food and Drug Administration on Wednesday approved Karyopharm Therapeutics Inc's treatment for multiple myeloma, a type of blood cancer.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)